BMO cuts C.H. Robinson price target, stays cautious on RXO deal
CHRW•BMO cut its price target on C.H. Robinson to $160 from $190 and reiterated its market perform rating. It called the RXO acquisition strategically compelling but said value creation depends on retaining shipment volumes, achieving productivity gains and managing integration and brokerage-liability risks.
1. Target cut and deal risks
BMO lowered its price target on C.H. Robinson Worldwide to $160 from $190 and reiterated its “marketperform” rating. The new target represents an 11.3% premium to the stock’s last close. BMO described the RXO acquisition as “strategically compelling and financially credible,” while cautioning that value creation depends on retaining RXO’s shipment volumes, achieving productivity gains, and managing integration and brokerage-liability risks.
